跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 2,607 条关于
“MGMT-unmethylated glioblastoma”
全部
2,607
临床试验
2,005
药物
50
机构
6
资讯
546
去年
Dual Checkpoint Inhibitor Therapy Fails to Improve Outcomes in MGMT-Unmethylated Glioblastoma
去年
Phase 3 Gliofocus Trial Aims to Improve Outcomes in MGMT Unmethylated Glioblastoma with Niraparib
去年
Gliofocus Study Expands Globally to Evaluate Niraparib in Glioblastoma
3天前
Imvax's IGV-001 Shows 40% Survival Gain in Unmethylated MGMT Glioblastoma Subgroup; FDA Aligns on Phase 3 Design
2年前
Moleculin Biotech's STAT3 Inhibitor WP1066 Enters Phase 2 Trial for Glioblastoma
去年
LAM561 Shows Promising PFS Data in MGMT-Methylated Glioblastoma Patients
去年
Veliparib Fails to Improve Survival in Glioblastoma Patients With MGMT Hypermethylation
10个月前
Phase 1 REGOMA-2 Trial Establishes Safe Dosing for Regorafenib Combination in MGMT-Methylated Glioblastoma
去年
FDA to Discuss Paxalisib Registration Pathways for Glioblastoma with Kazia Therapeutics
去年
Kazia Therapeutics to Meet with FDA on Paxalisib's Glioblastoma Registration Pathway
第 1 页，共 55 页
上一页
下一页
